National Healthcare Properties Series B Preferred (NHPBP)
Series B preferred shares of a senior housing and outpatient medical REIT.
$25.30
At close+0.01 (+0.04%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 86 | 87 | 88 | 89 | 89 | 88 | 86 | 85 | 86 | 84 | 86 | 88 |
| Cost of revenue | 54 | 56 | 55 | 55 | 56 | 55 | 58 | 54 | 54 | 53 | 53 | 90 |
| Gross profit | 31 | 31 | 33 | 34 | 33 | 33 | 29 | 31 | 32 | 31 | 33 | −2 |
| 32 | 37 | 34 | 134 | 53 | 34 | 16 | 37 | 30 | 38 | 23 | −11 | |
| 5 | 5 | 7 | 5 | 6 | 6 | 5 | 5 | 6 | 9 | 5 | 0 | |
| General & administrative | 5 | 5 | 7 | 5 | 6 | 6 | 5 | 5 | 6 | 9 | 5 | 0 |
| Other expenses | 28 | 33 | 28 | 130 | 48 | 28 | 11 | 32 | 24 | 29 | 18 | −11 |
| Operating income | −1 | −7 | −1 | −100 | −21 | −1 | 13 | −6 | 2 | −7 | 10 | 9 |
| −15 | −18 | −14 | −16 | −20 | −16 | −15 | −15 | −15 | −16 | −14 | −14 | |
| Interest income | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 16 | 16 | 16 | 18 | 18 | 17 | 15 | 16 | 15 | 16 | 15 | 13 |
| Other non-operating income | −1 | 2 | −2 | −1 | 2 | −1 | 0 | −1 | 0 | 0 | 0 | 2 |
| Income before tax | −16 | −25 | −15 | −117 | −41 | −17 | −2 | −21 | −12 | −23 | −4 | −5 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −16 | −25 | −16 | −117 | −41 | −17 | −2 | −21 | −13 | −23 | −4 | −5 |
| Other adjustments | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −16 | −25 | −16 | −116 | −41 | −17 | −2 | −21 | −13 | −23 | −4 | −5 |
| EPS, basic | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | −$0.11 | −$0.12 |
| EPS, diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | −$0.11 | −$0.12 |
| Weighted average shares, basic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68 | 62 |
| Weighted average shares, diluted | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68 | 62 |
| EBITDA | 21 | 12 | 21 | −77 | −2 | 21 | 39 | 14 | 21 | 11 | 28 | 25 |
| Depreciation & amortization | 21 | 20 | 20 | 22 | 21 | 21 | 26 | 19 | 18 | 18 | 18 | 18 |
| EBIT | 0 | −9 | 1 | −99 | −23 | 0 | 13 | −5 | 3 | −7 | 10 | 7 |
